Keyphrases
Thrombin
100%
Orally Active
100%
Bleeding Time
100%
Argatroban
100%
Thrombus Formation
66%
Vehicle Groups
66%
Oral Administration
33%
Inhibition Rate
33%
Potent Inhibitor
33%
Selective Inhibitor
33%
Rat Model
33%
Transection
33%
Venous Thrombosis
33%
Thrombotic
33%
Competitive Inhibitor
33%
Activated Partial Thromboplastin Time (aPTT)
33%
Vessel Patency
33%
Antithrombotic Agents
33%
Antithrombotic Effect
33%
Carotid Artery Thrombosis
33%
Stasis
33%
Thrombosis Model
33%
Iron(III) Chloride
33%
Rat Tail
33%
ID50
33%
Endothelial Disruption
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
100%
Thrombin
100%
Argatroban
100%
Anticoagulant Agent
66%
Thrombus
66%
Thromboplastin
33%
Thrombosis
33%
Rat Model
33%
Competitive Inhibitor
33%
Vein Thrombosis
33%
Carotid Artery Thrombosis
33%